医学
糖尿病
他汀类
胰岛素抵抗
机制(生物学)
临床试验
生物信息学
重症监护医学
内科学
内分泌学
生物
哲学
认识论
作者
Raghuvir Keni,A. Chandra Sekhar,Karthik Gourishetti,Pawan G. Nayak,Manas Kinra,Nitesh Kumar,Rekha R. Shenoy,Anoop Kishore,Krishnadas Nandakumar
标识
DOI:10.2174/1389450122666210120125945
摘要
Statins have transformed the treatment of cardiovascular diseases through primary and secondary prevention of events. Despite the success of statin's management of cardiovascular conditions, certain clinical trials, reviews, and meta-analysis point out that statins have the propensity to induce diabetes. The risk further increases with intensive statin therapy or in patients with diabetes. A proper mechanism for the induction of the diabetic condition has not yet been determined. The involvement of statin with beta cells in insulin secretion and peripheral cells in insulin resistance has been widely studied and established. The present review provides an update on the recent understanding of statin-induced diabetes. This covers the origin of statins, their development, possible mechanisms that explain the adverse effects in glucose homeostasis, and probable targets to remedy the condition.
科研通智能强力驱动
Strongly Powered by AbleSci AI